Therapeutic Group : Antibiotic Presentation: Lomeflox Tablet: Each film coated tablet contains Lomefloxacin HCl INN equivalent to Lomefloxacin 400 mg. Pharmacology: Lomefloxacin, a difluorioniated quinolone derivative, is a bacterial gyrase inhibitor, effective against gram positive and gram-negative bacteria. Lomefloxacin interferes with bacterial DNA related processes like initiation, elongation and termination phases of replication, transcription, DNA […]
Therapeutic Group : Cardiovascular Presentation: Lodipin 5 Tablet: Each tablet contains Amlodipine besilate BP equivalent to Amlodipine 5 mg. Indications: 1. Hypertension: Lodipin is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.2. Stable angina: Lodipin is indicated for the treatment of stable angina. It may […]
Therapeutic Group : Cardiovascular Presentation: Lodicard Tablet : Each tablet contains Amlodipine besilate BP equivalent to Amlodipine 5 mg and Atenolol BP 50 mg. Indications: Lodicard is indicated for the following conditions: 1) For the treatment of hypertension 2) For chronic stable angina 3) In post MI patients 4) In patients with refractory angina pectoris […]
Therapeutic Group : Anesthetic Presentation: Locaine Injection: Each ml contains Lidocaine Hydrochloride USP 20 mg. Indications: – To anaesthetize the area of the body where surgery is to be performed.– To provide pain relief in labour and after surgery. Dosage & Administration: The dosage is adjusted according to the response of the patient and site […]
Therapeutic Group : Farnesoid X receptor agonists Presentation: Livcare-5 Tablet: Each film coated tablet contains Obeticholic Acid INN 5 mg.Livcare-10 Tablet: Each film coated tablet contains Obeticholic Acid INN 10 mg. Pharmacology: Obeticholic Acid is a Farnesoid X Receptor (FXR) agonist, a nuclear receptor expressed in the liver and intestine. FXR is a key regulator […]
Therapeutic Group : Antidiabetic Oral Presentation: Linaglip-M 2.5/500 Tablet: Each film coated tablet contains Linagliptin INN 2.5 mg & Metformin Hydrochloride BP 500 mg.Linaglip-M 2.5/850 Tablet: Each film coated tablet contains Linagliptin INN 2.5 mg & Metformin Hydrochloride BP 850 mg.Linaglip-M 5/1000 ER Tablet: Each film coated tablet contains Linagliptin INN 5 mg & Metformin […]
Therapeutic Group : Antidiabetic Presentation: Linaglip Tablet: Each film coated tablet contains Linagliptin INN 5 mg. Indications: Linaglip is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Linaglip may be used as monotherapy or in combination with other common antidiabetic medications including Metformin, Sulfonylurea, […]
Therapeutic Group : Immunomodulator & LFA-1 Antagonist Presentation: Liftear Ophthalmic Solution: Each ml contains Lifitegrast INN 50 mgPreservative: Sodium Perborate BP 0.01% Pharmacology: Lifitegrast is a novel lymphocyte function associated antigen 1 (LFA-1) antagonist. Itacts by inhibiting LFA-1 interaction with the intercellular adhesion molecule (ICAM)-1on the T-cell surface, inhibiting T-cell adhesion, migration, activation and subsequentcytokine […]
Therapeutic Group : Enzyme Presentation: Laczym chewable tablet: Each chewable tablet contains Lactase USP 9000 IU. Indications: Laczym is indicated for preventing symptoms of lactose intolerance such as bloating, flatulence, diarrhea etc. Dosage & Administration: 1 tablet with dairy food. If needed dose can be adjusted up to 2 tablets at a time. Contrainidications: This […]
Therapeutic Group : Cardiovascular Presentation: Lacicard-2 Tablet: Each film coated tablet contains Lacidipine BP 2 mg.Lacicard-4 Tablet: Each film coated tablet contains Lacidipine BP 4 mg. Indications: Treatment of hypertension, either alone or in combination with other antihypertensive agents such as beta-blockers and diuretics. Dosage & Administration: Initially 2 mg as a single daily dose, […]